Literature DB >> 12557229

Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas.

Lucia Roque1, Raquel Rodrigues, António Pinto, Vasco Moura-Nunes, Jorge Soares.   

Abstract

The underlying genetic events associated with follicular thyroid tumorigenesis are still ill defined. In this study, we performed a screening for chromosome imbalances by comparative genomic hybridization (CGH) in a group of 12 follicular adenomas (FAs) and 20 follicular carcinomas (FTCs) previously characterized by conventional cytogenetics and flow cytometry analysis. In general, a great similarity was observed between the CGH profiles of the FAs and FTCs. In both benign and malignant tumors, a combination of gains affecting 5, 7, 12, 17, 19, and 20 was observed. Chromosome 7 was the most frequently affected chromosome, with three regions of consensus gains: 7p11-12, 7q11.3-q21, and 7q31. Recurrent gains of chromosomes 5 and 12 involved 5p11, 5p15, 5q13-q22, 5q21-q23, 12p11, and 12q11-q12. DNA sequence losses were also observed in both tumor groups. Chromosomal arms deleted in at least five of the neoplasms were (in order of frequency): in adenomas, 15q, 2p/2q, 3q, 6p/6q, 11q, and 22q; and in FTCs, 3p, 2p, 8q, 1p, 2q, 3q, 6q, 8p, 9p, 11q, 13q, 6p, and 18q. The statistical evaluation of the CGH data demonstrated that 15q loss was significantly associated with FA. Two regions of minimal common loss were defined by CGH at 15: 15q11-q21 and 15q26-qter. The identification of these regions provides a basis for further molecular studies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12557229     DOI: 10.1002/gcc.10146

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  18 in total

1.  A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Authors:  Janete M Cerutti; Rosana Delcelo; Marcelo João Amadei; Claudia Nakabashi; Rui M B Maciel; Bercedis Peterson; Jennifer Shoemaker; Gregory J Riggins
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Authors:  Ludovic Lacroix; Vladimir Lazar; Stefan Michiels; Hugues Ripoche; Philippe Dessen; Monique Talbot; Bernard Caillou; Jean-Pierre Levillain; Martin Schlumberger; Jean-Michel Bidart
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

3.  Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology.

Authors:  Ana T Pinto; Marta Pojo; Joana Simões-Pereira; Ruben Roque; Ana Saramago; Lúcia Roque; Carmo Martins; Saudade André; José Cabeçadas; Valeriano Leite; Branca M Cavaco
Journal:  Endocrine       Date:  2019-07-31       Impact factor: 3.633

4.  Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.

Authors:  Leonard Da Silva; Daniel James; Peter T Simpson; Daniel Walker; Ana Cristina Vargas; Janani Jayanthan; Sunil R Lakhani; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

5.  Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).

Authors:  Lothar Veits; Gunhild Mechtersheimer; Christina Steger; Jens Freitag; Gregor Mikuz; Kurt W Schmid; Walter Hofmann; Peter Schirmacher; Arndt Hartmann; Ralf J Rieker
Journal:  Virchows Arch       Date:  2011-07-07       Impact factor: 4.064

6.  Somatic amplifications and deletions in genome of papillary thyroid carcinomas.

Authors:  Nadia Passon; Elisa Bregant; Marialuisa Sponziello; Maria Dima; Francesca Rosignolo; Cosimo Durante; Marilena Celano; Diego Russo; Sebastiano Filetti; Giuseppe Damante
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

7.  Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.

Authors:  Hao Ying; Fumihiko Furuya; Li Zhao; Osamu Araki; Brian L West; John A Hanover; Mark C Willingham; Sheue-Yann Cheng
Journal:  J Clin Invest       Date:  2006-10-12       Impact factor: 14.808

8.  Genomic differences in benign and malignant follicular thyroid tumours using 1-Mb array-comparative genomic hybridisation.

Authors:  Abdul A Qureshi; V P Collins; P Jani
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-13       Impact factor: 2.503

9.  DNA copy number variations characterize benign and malignant thyroid tumors.

Authors:  Yan Liu; Leslie Cope; Wenyue Sun; Yongchun Wang; Nijaguna Prasad; Lauren Sangenario; Kristen Talbot; Helina Somervell; William Westra; Justin Bishop; Joseph Califano; Martha Zeiger; Christopher Umbricht
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

10.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.